This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo

Welcome to the new home of Guidelines in Practice

For Secondary Care| Video

The Experts Review: Whole Genome Sequencing

Four Leading Oncologists Discuss the Practicalities of Whole Genome Sequencing

In the first of a two-part video series, Dr Angela George, Professor Noel Clarke, Dr Nirupa Murugaesu, and Dr Richard Simcock reflect on the advantages and disadvantages of whole genome sequencing for patients and oncologists, and look at its impact on oncology survival rates.

They examine issues around data generation and management, cost, whether targets in the NHS Long Term Plan1 are achievable, and managing the backlog of care in the NHS.

Also available:

Part 2. Opportunities and threats for whole genome sequencing

Dr Angela George
Consultant Medical Oncologist, Consultant in OncoGenetics, and Clinical Director of Genomics, Royal Marsden Hospital, London

Professor Noel Clarke
Consultant Urological Surgeon, The Christie NHS Foundation Trust, Manchester; Professor of Urological Oncology, University of Manchester 

Dr Nirupa Murugaesu
Consultant in Medical Oncology, St George's Hospital; Cancer Genomics Medical Lead for the London South Genomics Laboratory Hub

Dr Richard Simcock
Consultant Clinical Oncologist, University Hospitals Sussex, Brighton; National Clinical Adviser for Macmillan Cancer Support